{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:35:14Z","timestamp":1787726114167,"version":"build-2784847793"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s00417-025-06880-z","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T11:20:54Z","timestamp":1754392854000},"page":"2997-3007","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and clinical outcomes of suprachoroidal triamcinolone acetonide in diabetic macular edema patients: a single-arm systematic review and meta-analysis"],"prefix":"10.1007","volume":"263","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2840-7593","authenticated-orcid":false,"given":"Mohammad","family":"Karam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moath","family":"Baeshen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaldon","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lojain","family":"Jamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaynab","family":"Maqwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman","family":"Alotaibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talal","family":"Alabduljalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,5]]},"reference":[{"key":"6880_CR1","doi-asserted-by":"crossref","unstructured":"Blinder KJ, Dugel PU, Chen S, Jumper JM, Walt JG, Hollander DA et al (2017) Anti-VEGF treatment of diabetic macular edema in clinical practice: effectiveness and patterns of use (ECHO study report 1). Clin Ophthalmol 11:393\u2013401","DOI":"10.2147\/OPTH.S128509"},{"key":"6880_CR2","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1159\/000455277","volume":"58","author":"F Bandello","year":"2017","unstructured":"Bandello F, Parodi MB, Lanzetta P, Loewenstein A, Massin P, Menchini F et al (2017) Diabetic macular edema. Macular Edema 58:102\u2013138","journal-title":"Macular Edema"},{"key":"6880_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12886-018-0779-1","volume":"18","author":"Y He","year":"2018","unstructured":"He Y, Ren X-j, Hu B-j, Lam W-C, Li X-r (2018) A meta-analysis of the effect of a dexamethasone intravitreal implant versus intravitreal anti-vascular endothelial growth factor treatment for diabetic macular edema. BMC Ophthalmol 18:1\u201311","journal-title":"BMC Ophthalmol"},{"issue":"6","key":"6880_CR4","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/j.ophtha.2016.02.022","volume":"123","author":"DRCR Network","year":"2016","unstructured":"Network DRCR, Aflibercept (2016) Bevacizumab, or Ranibizumab for diabetic macular edema Two-Year results from a comparative effectiveness randomized clinical trial. Ophthalmology 123(6):1351\u20131359","journal-title":"Ophthalmology"},{"issue":"4","key":"6880_CR5","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1159\/000458539","volume":"237","author":"U Schmidt-Erfurth","year":"2017","unstructured":"Schmidt-Erfurth U, Garcia-Arumi J, Bandello F, Berg K, Chakravarthy U, Gerendas BS et al (2017) Guidelines for the management of diabetic macular edema by the European society of retina specialists (EURETINA). Ophthalmologica 237(4):185\u2013222","journal-title":"Ophthalmologica"},{"issue":"4","key":"6880_CR6","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1038\/eye.2017.305","volume":"32","author":"P Fossum","year":"2018","unstructured":"Fossum P, Couret C, Briend B, Weber M, Lagarce L (2018) Safety of intravitreal injection of Ranibizumab in early pregnancy: a series of three cases. Eye 32(4):830\u2013832","journal-title":"Eye"},{"issue":"1","key":"6880_CR7","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/s41598-020-57509-6","volume":"10","author":"YK Kang","year":"2020","unstructured":"Kang YK, Park HS, Park DH, Shin JP (2020) Incidence and treatment outcomes of secondary epiretinal membrane following intravitreal injection for diabetic macular edema. Sci Rep 10(1):528","journal-title":"Sci Rep"},{"key":"6880_CR8","doi-asserted-by":"crossref","unstructured":"Grover DA, Li T, Chong CC (2022). Intravitreal steroids for macular edema in diabetes. Cochrane Database Syst Rev 2008(1)","DOI":"10.1002\/14651858.CD005656.pub2"},{"key":"6880_CR9","first-page":"41","volume":"4","author":"P Lanzetta","year":"2009","unstructured":"Lanzetta P, Veritti D (2009) The role of steroids in the treatment of diabetic macular edema. Retina Today 4:41\u201344","journal-title":"Retina Today"},{"key":"6880_CR10","unstructured":"Nozik R (1972) Periocular injection of steroids. Transactions-American academy of ophthalmology and otolaryngology. American academy of ophthalmology and otolaryngology. 76(3):695\u2013705"},{"issue":"11","key":"6880_CR11","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.18240\/ijo.2020.11.13","volume":"13","author":"M Zhao","year":"2020","unstructured":"Zhao M, Zhang C, Chen X-M, Teng Y, Shi T-W, Liu F (2020) Comparison of intravitreal injection of conbercept and triamcinolone acetonide for macular edema secondary to branch retinal vein occlusion. Int J Ophthalmol 13(11):1765","journal-title":"Int J Ophthalmol"},{"issue":"8","key":"6880_CR12","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1097\/IAE.0b013e318285cc52","volume":"33","author":"MR Munk","year":"2013","unstructured":"Munk MR, Bolz M, Huf W, Sulzbacher F, Roberts P, Simader C et al (2013) Morphologic and functional evaluations during development, resolution, and relapse of uveitis-associated cystoid macular edema. Retina 33(8):1673\u20131683","journal-title":"Retina"},{"issue":"41","key":"6880_CR13","doi-asserted-by":"publisher","first-page":"4903","DOI":"10.2174\/1381612825666190130140717","volume":"24","author":"VM Villegas","year":"2018","unstructured":"Villegas VM, Schwartz SG (2018) Current and future Pharmacologic therapies for diabetic retinopathy. Curr Pharm Design 24(41):4903\u20134910","journal-title":"Curr Pharm Design"},{"key":"6880_CR14","doi-asserted-by":"crossref","unstructured":"Urban\u010di\u010d M, Garda\u0161evi\u0107 Top\u010di\u0107 I (2019) Dexamethasone implant in the management of diabetic macular edema from clinician\u2019s perspective. Clin Ophthalmol 13:829\u2013840","DOI":"10.2147\/OPTH.S206769"},{"key":"6880_CR15","doi-asserted-by":"crossref","unstructured":"SOO GEUN J, Moon H, Chae J (2013) The effect of posterior subtenon injection of triamcinolone acetonide for diabetic macular edema refractory to intravitreal bevacizumab injection. Acta Ophthalmol 91:3468","DOI":"10.1111\/j.1755-3768.2013.3468.x"},{"issue":"7","key":"6880_CR16","doi-asserted-by":"publisher","first-page":"967","DOI":"10.3390\/pharmaceutics13070967","volume":"13","author":"L Naftali Ben Haim","year":"2021","unstructured":"Naftali Ben Haim L, Moisseiev E (2021) Drug delivery via the suprachoroidal space for the treatment of retinal diseases. Pharmaceutics 13(7):967","journal-title":"Pharmaceutics"},{"key":"6880_CR17","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1159\/000431193","volume":"55","author":"N Yamada","year":"2016","unstructured":"Yamada N, Olsen TW (2016) Routes for drug delivery to the retina: topical, transscleral, suprachoroidal and intravitreal gas phase delivery. Retinal Pharmacotherapeutics 55:71\u201383","journal-title":"Retinal Pharmacotherapeutics"},{"issue":"13","key":"6880_CR18","first-page":"5259","volume":"55","author":"HF Edelhauser","year":"2014","unstructured":"Edelhauser HF, Verhoeven RS, Burke B, Struble CB, Patel SR (2014) Intraocular distribution and targeting of triamcinolone acetonide suspension administered into the suprachoroidal space. Investig Ophthalmol Vis Sci 55(13):5259","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"10","key":"6880_CR19","doi-asserted-by":"publisher","first-page":"e48188","DOI":"10.1371\/journal.pone.0048188","volume":"7","author":"P Tyagi","year":"2012","unstructured":"Tyagi P, Kadam RS, Kompella UB (2012) Comparison of suprachoroidal drug delivery with subconjunctival and intravitreal routes using noninvasive fluorophotometry. PLoS ONE 7(10):e48188","journal-title":"PLoS ONE"},{"issue":"2","key":"6880_CR20","first-page":"42","volume":"36","author":"H Tayyab","year":"2020","unstructured":"Tayyab H, Ahmed CN, Sadiq MAA (2020) Efficacy and safety of suprachoroidal triamcinolone acetonide in cases of resistant diabetic macular edema. Pakistan J Med Sci 36(2):42","journal-title":"Pakistan J Med Sci"},{"key":"6880_CR21","doi-asserted-by":"crossref","unstructured":"Abdelshafy Tabl A, Tawfik Soliman T, Anany Elsayed M, Abdelshafy Tabl M (2022) A randomized trial comparing suprachoroidal and intravitreal injection of triamcinolone acetonide in refractory diabetic macular edema due to epiretinal membrane. J Ophthalmol 2022","DOI":"10.1155\/2022\/7947710"},{"issue":"11","key":"6880_CR22","doi-asserted-by":"publisher","first-page":"592","DOI":"10.53350\/pjmhs20221611592","volume":"16","author":"HH Akhlaq","year":"2022","unstructured":"Akhlaq HH, Shah FA, Ahsen M, Hassan SA, Zahid K, Wattoo RR (2022) Efficacy and safety of suprachoroidal administration of triamcinolone acetonide in patients of refractory diabetic macular edema. Pakistan J Med Health Sci 16(11):592","journal-title":"Pakistan J Med Health Sci"},{"issue":"06","key":"6880_CR23","doi-asserted-by":"publisher","first-page":"304","DOI":"10.53350\/pjmhs22166304","volume":"16","author":"F Anwar","year":"2022","unstructured":"Anwar F, Khan AA, Majhu TM, Javaid RMM, Ghaffar MT, Bokhari MH (2022) Comparison of suprachoroidal injection of triamcinolone acetonide versus intravitreal bevacizumab in primary diabetic macular Odema. Pakistan J Med Health Sci 16(06):304","journal-title":"Pakistan J Med Health Sci"},{"issue":"11","key":"6880_CR24","doi-asserted-by":"publisher","first-page":"400","DOI":"10.53350\/pjmhs20221611400","volume":"16","author":"A Chandni","year":"2022","unstructured":"Chandni A, Sharfe Rehman Bhatti FK, Ijaz M, Rafique D, Choudhry TA (2022) To determine the efficacy of suprachoroidal triamcinolone injection for the treatment of refractory diabetic macular edema. Pakistan J Med Health Sci 16(11):400","journal-title":"Pakistan J Med Health Sci"},{"issue":"4","key":"6880_CR25","doi-asserted-by":"publisher","first-page":"030006052210898","DOI":"10.1177\/03000605221089807","volume":"50","author":"A Marashi","year":"2022","unstructured":"Marashi A, Zazo A (2022) Suprachoroidal injection of triamcinolone acetonide using a custom-made needle to treat diabetic macular edema post Pars plana vitrectomy: A case series. J Int Med Res 50(4):03000605221089807","journal-title":"J Int Med Res"},{"key":"6880_CR26","doi-asserted-by":"publisher","first-page":"3821","DOI":"10.2147\/OPTH.S391319","volume":"16","author":"AE Nawar","year":"2022","unstructured":"Nawar AE (2022) Effectiveness of suprachoroidal injection of triamcinolone acetonide in resistant diabetic macular edema using a modified microneedle. Clin Ophthalmol (Auckland NZ) 16:3821","journal-title":"Clin Ophthalmol (Auckland NZ)"},{"key":"6880_CR27","doi-asserted-by":"crossref","unstructured":"Zakaria YG, Salman AG, Said AMA, Abdelatif MK (2022) Suprachoroidal versus intravitreal triamcinolone acetonide for the treatment of diabetic macular edema. Clin Ophthalmol 16:733\u2013746","DOI":"10.2147\/OPTH.S351853"},{"issue":"01","key":"6880_CR28","doi-asserted-by":"publisher","first-page":"324","DOI":"10.53350\/pjmhs2023171324","volume":"17","author":"Y Ahmad","year":"2023","unstructured":"Ahmad Y, Memon SUH, Bhatti SA, Nawaz F, Ahmad W, Saleem M (2023) Efficacy and safety of suprachoroidal triamcinolone acetonide in cases of resistant diabetic macular edema. Pakistan J Med Health Sci 17(01):324","journal-title":"Pakistan J Med Health Sci"},{"key":"6880_CR29","doi-asserted-by":"publisher","first-page":"239","DOI":"10.47391\/JPMA.2239","volume":"73","author":"A Ateeq","year":"2023","unstructured":"Ateeq A, Majid S, Memon NA, Hayat N, Somroo AQ, Fattah A (2023) Suprachoroidal injection of triamcinolone acetonide for management of resistant diabetic macular oedema. JPMA J Pak Med Assoc 73:239\u2013244","journal-title":"JPMA J Pak Med Assoc"},{"issue":"12","key":"6880_CR30","doi-asserted-by":"publisher","first-page":"4563","DOI":"10.1007\/s10792-023-02856-2","volume":"43","author":"E Tharwat","year":"2023","unstructured":"Tharwat E, Ahmed REH, Eltantawy B, Ezzeldin ER, Elgazzar AF (2023) Suprachoroidal triamcinolone versus posterior subtenon triamcinolone either alone or formulated in the management of diabetic macular edema. Int Ophthalmol 43(12):4563\u20134571","journal-title":"Int Ophthalmol"},{"issue":"5","key":"6880_CR31","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ijsu.2010.02.007","volume":"8","author":"D Moher","year":"2010","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2010) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 8(5):336\u2013341","journal-title":"Int J Surg"},{"key":"6880_CR32","volume-title":"Quality assessment tool for before-after (pre-post) studies with no control group. Systematic evidence reviews and clinical practice guidelines Washington","author":"Health NIo","year":"2014","unstructured":"Health NIo (2014) Quality assessment tool for before-after (pre-post) studies with no control group. Systematic evidence reviews and clinical practice guidelines Washington. National Institutes of Health,, DC"},{"issue":"06","key":"6880_CR33","doi-asserted-by":"publisher","first-page":"301","DOI":"10.53350\/pjmhs22166301","volume":"16","author":"MH Shahid","year":"2022","unstructured":"Shahid MH, Rashid F, Tauqeer S, Ali R, Farooq MT, Aleem N (2022) Comparison of suprachoroidal triamcinolone injection with intravitreal bevacizumab vs intravitreal bevacizumab only in treatment of refractory diabetic macular edema. Pakistan J Med Health Sci 16(06):301","journal-title":"Pakistan J Med Health Sci"},{"issue":"1","key":"6880_CR34","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12886-023-02790-y","volume":"23","author":"F Fazel","year":"2023","unstructured":"Fazel F, Malekahmadi M, Feizi A, Oliya B, Tavakoli M, Fazel M (2023) Suprachoroidal injection of triamcinolone acetonide plus intravitreal bevacizumab in diabetic macular edema: a randomized pilot trial. BMC Ophthalmol 23(1):40","journal-title":"BMC Ophthalmol"},{"issue":"1","key":"6880_CR35","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.oret.2020.08.007","volume":"5","author":"MR Barakat","year":"2021","unstructured":"Barakat MR, Wykoff CC, Gonzalez V, Hu A, Marcus D, Zavaleta E et al (2021) Suprachoroidal CLS-TA plus intravitreal Aflibercept for diabetic macular edema: a randomized, double-masked, parallel-design, controlled study. Ophthalmol Retina 5(1):60\u201370","journal-title":"Ophthalmol Retina"},{"issue":"4","key":"6880_CR36","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1097\/IAE.0b013e3182278b0e","volume":"32","author":"S Rizzo","year":"2012","unstructured":"Rizzo S, Ebert FG, Di Bartolo E, Barca F, Cresti F, Augustin C et al (2012) Suprachoroidal drug infusion for the treatment of severe subfoveal hard exudates. Retina 32(4):776\u2013784","journal-title":"Retina"},{"issue":"1","key":"6880_CR37","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s40123-022-00603-x","volume":"12","author":"S Yeh","year":"2023","unstructured":"Yeh S, Henry CR, Kapik B, Ciulla TA (2023) Triamcinolone acetonide suprachoroidal injectable suspension for uveitic macular edema: integrated analysis of two phase 3 studies. Ophthalmol Therapy 12(1):577\u2013591","journal-title":"Ophthalmol Therapy"},{"issue":"05","key":"6880_CR38","doi-asserted-by":"publisher","first-page":"164","DOI":"10.53350\/pjmhs22165164","volume":"16","author":"MS Munir","year":"2022","unstructured":"Munir MS, Rehman R, Nazir S, Sharif N, Chaudhari MZ, Saleem S (2022) Visual outcome after suprachoroidal injection of triamcinolone acetate in cystoid macular edema of different pathology. Pakistan J Med Health Sci 16(05):164","journal-title":"Pakistan J Med Health Sci"},{"issue":"8","key":"6880_CR39","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1136\/bjo.2006.090340","volume":"90","author":"DJ Rhee","year":"2006","unstructured":"Rhee DJ, Peck RE, Belmont J, Martidis A, Liu M, Chang J et al (2006) Intraocular pressure alterations following intravitreal triamcinolone acetonide. Br J Ophthalmol 90(8):999\u20131003","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"6880_CR40","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/sj.eye.6701895","volume":"20","author":"JP Kersey","year":"2006","unstructured":"Kersey JP, Broadway DC (2006) Corticosteroid-induced glaucoma: a review of the literature. Eye (Lond) 20(4):407\u2013416","journal-title":"Eye (Lond)"},{"issue":"4","key":"6880_CR41","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.oret.2017.07.013","volume":"2","author":"PA Campochiaro","year":"2018","unstructured":"Campochiaro PA, Wykoff CC, Brown DM, Boyer DS, Barakat M, Taraborelli D et al (2018) Suprachoroidal triamcinolone acetonide for retinal vein occlusion: results of the Tanzanite study. Ophthalmol Retina 2(4):320\u2013328","journal-title":"Ophthalmol Retina"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-025-06880-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-025-06880-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-025-06880-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T03:50:38Z","timestamp":1764820238000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-025-06880-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,5]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["6880"],"URL":"https:\/\/doi.org\/10.1007\/s00417-025-06880-z","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,5]]},"assertion":[{"value":"17 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers\u2019 bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}